NCT00027144View on ClinicalTrials.gov

Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2000

Study Completion Date

October 31, 2002

Conditions
Leukemia,Myeloid, ChronicLeukemia,Myeloid,Philadelphia-Positive
Interventions
BIOLOGICAL

Heat Shock Protein 70 HSP70

Trial Locations (1)

06030

University of Connecticut Health Center, Farmington

All Listed Sponsors
lead

University of Connecticut

OTHER

NCT00027144 - Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase | Biotech Hunter | Biotech Hunter